|
|
| (4 intermediate revisions by 4 users not shown) |
| Line 1: |
Line 1: |
| __NOTOC__
| |
| {{Cervical dysplasia}}
| |
| {{CMG}}
| |
|
| |
|
| ==Overview==
| |
|
| |
|
| ==Pap Smear==
| | #REDIRECT[[Cervical cancer screening]] |
| Cervical dysplasia that is seen on a Pap smear is called squamous intraepithelial lesion (SIL). These changes may be graded as: | |
| | |
| *Low-grade (LSIL)
| |
| *High-grade (HSIL)
| |
| *Possibly cancerous (malignant)
| |
| | |
| If a Pap smear shows abnormal cells or cervical dysplasia, further testing or monitoring will be recommended:
| |
| | |
| *Follow-up Pap smears may be recommended for mild cases
| |
| *Colposcopy-directed biopsy can confirm the condition
| |
| *Cone biopsy may be done after colposcopy
| |
| | |
| Dysplasia that is seen on a biopsy of the cervix is called cervical intraepithelial neoplasia (CIN). It is grouped into three categories:
| |
| | |
| *CIN I -- mild dysplasia
| |
| *CIN II -- moderate to marked dysplasia
| |
| *CIN III -- severe dysplasia to carcinoma in situ
| |
| | |
| Some strains of human papillomavirus (HPV) are known to cause cervical cancer. An HPV DNA test can identify the high-risk types of HPV linked to such cancer. This may be done:
| |
| | |
| *As a screening test for women over age 30
| |
| *For women of any age who have a slightly abnormal Pap test result
| |
| | |
| ==References==
| |
| {{reflist|2}}
| |
| | |
| {{WikiDoc Help Menu}}
| |
| {{WikiDoc Sources}}
| |